fingolimod mylan
mylan ireland limited - fingolimod hydrochloride - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 ja 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
pemetrexed mylan 25 mg/ml infuusiokonsentraatti, liuosta varten
mylan ab - pemetrexed - infuusiokonsentraatti, liuosta varten - 25 mg/ml - pemetreksedi
enalapril mylan 2.5 mg tabletti
mylan ab - enalaprili maleas - tabletti - 2.5 mg - enalapriili
enalapril mylan 5 mg tabletti
mylan ab - enalaprili maleas - tabletti - 5 mg - enalapriili
enalapril mylan 10 mg tabletti
mylan ab - enalaprili maleas - tabletti - 10 mg - enalapriili
enalapril mylan 20 mg tabletti
mylan ab - enalaprili maleas - tabletti - 20 mg - enalapriili
carboplatin mylan 10 mg/ml infuusiokonsentraatti, liuosta varten
mylan ireland limited mylan ireland limited - carboplatinum - infuusiokonsentraatti, liuosta varten - 10 mg/ml - karboplatiini
bortezomib mylan 3.5 mg injektiokuiva-aine, liuosta varten
mylan hospital as - bortezomibum - injektiokuiva-aine, liuosta varten - 3.5 mg - bortetsomibi
dutasteride mylan 0.5 mg kapseli, pehmeä
mylan ab - dutasteridum - kapseli, pehmeä - 0.5 mg - dutasteridi
sorafenib mylan 200 mg tabletti, kalvopäällysteinen
mylan ab - sorafenib tosilate - tabletti, kalvopäällysteinen - 200 mg - sorafenibi